Chinook Therapeutics
Clinical-stage biopharmaceutical company focused on developing precision medicines for kidney diseases. Acquired by Novartis in 2023 for $3.5 billion.
Website
https://www.chinooktx.comLocation
Seattle, Washington & Vancouver, British Columbia
Founded
2019
Investors
1
Categories
biotech, nephrology, kidney-disease, therapeutics, autoimmune
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |
